2018
DOI: 10.1021/acsbiomaterials.7b01037
|View full text |Cite
|
Sign up to set email alerts
|

Engineered coatings for titanium implants to present ultra-low doses of BMP-7

Abstract: The ongoing research to improve the clinical outcome of titanium implants has resulted in the implemetation of multiple approches to deliver osteogenic growth factors accelerating and sustaining osseointegration. Here we show the presentation of human bone morphogenetic protein 7 (BMP-7) adsorbed to titanium discs coated with poly(ethyl acrylate) (PEA). We have previously shown that PEA promotes fibronectin organization into nanonetworks exposing integrin- and growth-factor-binding domains, allowing a synergis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(28 citation statements)
references
References 51 publications
1
23
0
Order By: Relevance
“…This simple engineering approach exploits the synergistic presentation of BMP-2 on the FN material-driven networks, and was shown to drive significant bone regeneration in a critical size defect in vivo [ 130 ]. This system has also been used to coat titanium implants to present ultralow doses of BMP-7, with the aim to improve the bio-integration of titanium implants [ 143 ], and further to this, by tethering vascular endothelial growth factor (VEGF) improved vascularization of biomaterial scaffolds was achieved in vivo [ 144 ].
Figure 4.
…”
Section: Differentiationmentioning
confidence: 99%
“…This simple engineering approach exploits the synergistic presentation of BMP-2 on the FN material-driven networks, and was shown to drive significant bone regeneration in a critical size defect in vivo [ 130 ]. This system has also been used to coat titanium implants to present ultralow doses of BMP-7, with the aim to improve the bio-integration of titanium implants [ 143 ], and further to this, by tethering vascular endothelial growth factor (VEGF) improved vascularization of biomaterial scaffolds was achieved in vivo [ 144 ].
Figure 4.
…”
Section: Differentiationmentioning
confidence: 99%
“…Using DED technology, the characteristics of the surface can be controlled to create ideal porous surfaces with ideal pore size and maximum roughness [9,41]. In addition, adding an antibacterial and bioactive coating to the titanium surface increases the efficiency of osseointegration and prevents infection [42][43][44].…”
Section: Discussionmentioning
confidence: 99%
“…The bioreactor system has already been sent to a number of research labs, running successful experiments with minimal training from the authors here and using a variety of cultureware formats, as validated in this paper. In fact, the first clinical evaluation of surgical bone graft using mechanically stimulated MSCs, created with this bioreactor platform, and a 3D polycaprolactone (PCL) construct coated in layers of poly(ethyl acrylate) (PEA), fibronectin (FN) and growth factor BMP-2 4143 is scheduled for 2020/21, funded by the landmine charity Find A Better Way 44 . As well as the cost-effective production of the system, there is also the possibility of substantial cost savings to be made by healthcare organisations when using the bioreactor to produce cellular bone graft material for surgery in orthopaedic patients.…”
Section: Discussionmentioning
confidence: 99%